EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patients‐Derived Organoids Sequencing‐based FOXP4 Facilitates Radioresistance by Transcriptionally Modifying GPX4 to Regulate ferroptosis in Colorectal Cancer

Qianping Chen, Yuzhao Jin, Luyu Liao, Rong Shen, Xingnan Ge, Qingyu Jiang, Ying Huang, Quanquan Sun, Dong Liu, Luying Liu, Tongxin Liu, Qinghui Dai und 6 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202507080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Qianping Chen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Abdominal Radiotherapy, Zhejiang Cancer Hospital, Hangzhou, 310022, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Colorectal Neoplasms, Forkhead Transcription Factors, Organoids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research Development Program of Zhejiang, Zhejiang Natural Science Foundation, Zhejiang Provincial Medical and Health Science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

More than 50% of patients with colorectal cancer (CRC) exhibit radioresistance, indicating the need for further research on the disease. Therefore, the aim of this study is to identify radioresistance genes and elucidate the underlying molecular mechanisms using patient‐derived organoids (PDOs). Transcriptome analyses are performed on radio‐resistant and ‐sensitive PDOs, CRC cells, and xenograft tissues to screen for radioresistant genes. Additionally, the genetic homology between PDOs and clinical tissues is verified using whole‐exome sequencing. Functional experiments are performed to validate the roles of the candidate genes using cellular, organoid, and animal models. Forkhead box P4 (FOXP4) is identified as a differentially expressed genes between the radio‐sensitive and ‐resistant groups that is linked to radioresistance. Further experiments show that FOXP4 promoted radioresistance by suppressing ferroptosis. Mechanistically, FOXP4 regulated GPX4 transcription by binding to the promoter region of GPX4 via the forkhead domain to inhibit the onset of ferroptosis. Doxorubicin (DOX) inhibited FOXP4 expression by promoting its ubiquitination and degradation, eventually increasing radiosensitivity. Notably, DOX combined with irradiation attenuated the compensatory increase in FOXP4 expression and increased radiotherapy efficacy. Conclusively, the combination therapy provides a new strategy for enhancing therapeutic efficacy in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisColorectal NeoplasmsForkhead Transcription FactorsOrganoidsRadiation TolerancePhospholipid Hydroperoxide Glutathione PeroxidaseHumansMiceAnimalsGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

FOXP4FerroptosisGPX4PDOsRadioresistance

Substanzen

Forkhead Transcription FactorsPhospholipid Hydroperoxide Glutathione Peroxidase

Autor:innen und Institutionen

  • Department of Abdominal Radiotherapy, Zhejiang Cancer Hospital, Hangzhou, 310022, P. R. China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, P. R. China.
  • Wenzhou Medical University, Wenzhou, 325000, P. R. China.
  • School of Basic Medical Sciences, Lanzhou University, Gansu, 730000, P. R. China.
  • Zhejiang Chinese Medicine University, Hangzhou, 310053, P. R. China.
  • Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430200, P. R. China.

ORCID-Profile: Ji Zhu

Förderung

  • Key Research Development Program of Zhejiang
  • Zhejiang Natural Science Foundation
  • Zhejiang Provincial Medical and Health Science and Technology Plan
  • National Natural Science Foundation of China (NSFC)
  • China Postdoctoral Science Foundation

Zitieren

APA

Chen, Q., Jin, Y., Liao, L., Shen, R., Ge, X., Jiang, Q., Huang, Y., Sun, Q., Liu, D., Liu, L., Liu, T., Dai, Q., Tang, X., Han, Z., Gao, X., Lin, X., Mao, W., & Zhu, J. (2025). Patients‐Derived Organoids Sequencing‐based FOXP4 Facilitates Radioresistance by Transcriptionally Modifying GPX4 to Regulate ferroptosis in Colorectal Cancer. Advanced Science. https://doi.org/10.1002/advs.202507080

Vancouver

Chen Q, Jin Y, Liao L, Shen R, Ge X, Jiang Q, et al. Patients‐Derived Organoids Sequencing‐based FOXP4 Facilitates Radioresistance by Transcriptionally Modifying GPX4 to Regulate ferroptosis in Colorectal Cancer. Advanced Science. 2025. doi:10.1002/advs.202507080

BibTeX
@article{Chen2025,
  author = {Chen, Qianping and Jin, Yuzhao and Liao, Luyu and Shen, Rong and Ge, Xingnan and Jiang, Qingyu and Huang, Ying and Sun, Quanquan and Liu, Dong and Liu, Luying and Liu, Tongxin and Dai, Qinghui and Tang, Xiyuan and Han, Zhe and Gao, Xin and Lin, Xinhua and Mao, Wei and Zhu, Ji},
  title = {Patients‐Derived Organoids Sequencing‐based FOXP4 Facilitates Radioresistance by Transcriptionally Modifying GPX4 to Regulate ferroptosis in Colorectal Cancer},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202507080}
}
Kostenlos starten →